1. Fettig Jade, Mahesh S, Christopher S, Jonathan E. Global Epidemiology of HIV.

Infect
Dis Clin North Am. 2014 September ; 28(3): 323–337.
2. Zulfiqar HF, Aneeqa J, Sumbal, Bakht A, Qurban A, Khadija A et al. HIV diagnosed and
treatment through advanced technologies. Frontiers in public health. 2017.
3. Tüzüner Uğur , Begüm SG, Mehmet O. Laboratory Algorithm in HIV
4. Infection Diagnosis.2016. J HIV Clin Scientific Res 3(1): 007-010.
5. Yadalla HKK, Gandikota R. Cutaneous Cryptococcosis: A Marker Of Life
Threatening Disseminated Cryptococcosis In HIV AIDS. Our Dermatol Online. 2011;
2(4): 203-206.
6. Kiertiburanakul Sasisopin, Pawinee L, Somnuek S. Clinical Characteristics of HIV-
Infected Patients Who Survive after the Diagnosis of HIV Infection for More Than 10
Years in a Resource-Limited Setting. Journal of the International Association of
Physicians in AIDS Care 11(6) 361-365.
7. Zacharia Annett, Muhammad FK, Anne EH, Appalanaidu S,Michael AL,Joanne TM.
Case of Disseminated Cryptococcosis With Skin Manifestations in a Patient With
Newly Diagnosed HIV. J La State Med Soc; 2013.
8. Srivastava, Ragini T, Jyoti Y, Manish B, Cutaneous Cryptococcus: marker for
disseminated infection . BMJ Case Rep 2015.
9. Li Wei Gao, An Xia Jiao, Xi Rong Wu, Shun Ying Zhao, Yun Ma, Gang Liu, Ju Yin,
Bao Ping Xu KLS. Clinical characteristics of disseminated cryptococcosis in
previously healthy children in China. BMC Infect Dis. 2017;17:359.
10. adalla H, Rao G. Cutaneous cryptococcosis: A marker of life threatening disseminated
cryptococcosis in HIV AIDS. Our Dermatol Online. 2011;2(4):203–6.
11. Islam Amna, Imran A. Cryptococcal Meningitis: A Deadly Fungal Disease of Peoples
Living with HIV/ AIDS: Improving Access to Essential Antifungal Medicines: A Review
Study. J Prev Infect Cntrol; 2018. Vol.4.
12. Eileen K. Maziarz JRP. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179–
206.
13. Drogari‐Apiranthitou M, Theodoropoulos K, Petrikkos G, Tsiodras S, Chrisofos M,
Tofas P, et al. Primary cutaneous cryptococcosis and a surprise finding in a chronically
immunosuppressed patient. JMM Case Reports. 2014;1(3).
14. Ying-Yi Lu, Chieh-Shan Wu C-HH. Primary cutaneous cryptococcosis in an
immunocompetent man: A case report. Dermatologica Sin. 2013;31:90–3.
15. Robiatul Adawiyah RW. Kriptokokosis : Epidemiologi, Manifestasi Klinis dan
Diagnosis. Maj Kedokt FK UKI. 2012;28(3):133–43
1. Thomas L. Walsh, Nitin Bhanot, Monika A. Murillo, Jeffrey M. Uchin ZM. Creeping
Skin Lesions: Primary Cutaneous Cryptococcosis. Am J Med. 2017;17:1–6.
2. Quartaralo N, Thomas I, Li H, Weiderkehr, Schwartz RA LW. Cutaneous cryptococcosis.
Acta dermatol. 2002;11(4).
3. Landucci G, Farinelli P, Zavattaro E, Giorgione R, Gironi LC, Veronese F, Astolfi S,
Tiberio R, Boldorini RL CE and SP. Complete Remission of Primary Cutaneous
 Cryptococcosis in an Immunosuppressed Patient after Fluconazole Treatment. J Infect Dis
Ther. 2017;5(4):1–3.
4. K Wolff, L Goldsmith, S Katz, B Gilchrest, AS Paller DL. Fitzpatrick’s Dermatology in
General Medicine, 8th Edition. 8th ed. New York: McGraw-Hill; 2011.
5. Eileen K. Maziarz JRP. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179–206.
6. Moskowitz DG. Cutaneous Cryptococcus [Internet]. 2016. Available from:
https://emedicine.medscape.com
7. Du L, Yang Y, Gu J, Chen J LW. Systemic Review of Published Reports on Primary
Cutaneous Cryptococcosis in Immunocompetent Patients. Mycopathologia. 2015;180:19–
25.
8. Vasanthi S, Padmavathy BK, Gopal R, Sundaram RS, Manoharan G. Cutaneous
cryptococcosis among HIV infected patients. Indian J Med Microbiol [Internet].
2002;20(3):165–6. Available from:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citati
on&list_uids=17657060
9. Li Wei Gao, An Xia Jiao, Xi Rong Wu, Shun Ying Zhao, Yun Ma, Gang Liu, Ju Yin, Bao
Ping Xu KLS. Clinical characteristics of disseminated cryptococcosis in previously
healthy children in China. BMC Infect Dis. 2017;17:359.
10. Joshi NS, Fisher BT, Prasad PA Z TE. Epidemiology of cryptococcal infection in
hospitalized children. Pediatr Infect Dis J. 2010;29:91–5.
11. Perfect J. Cryptococcus neoformans and Cryptococcus gattii. In: Mandell, Douglas, and
Bennett’s principles and practice of infectious diseases. 2015. p. 2934–48.
12. Rajetha D, Janaki C, Sentaiselvi G JV. Disseminated cutaneous cryptococcosis in a patient
with HIV infection. Indian J Dermatol. 2004;49:90–2.
13. Yadalla H, Rao G. Cutaneous cryptococcosis: A marker of life threatening disseminated
cryptococcosis in HIV AIDS. Our Dermatol Online. 2011;2(4):203–6.
14. Drogari‐Apiranthitou M, Theodoropoulos K, Petrikkos G, Tsiodras S, Chrisofos M, Tofas
P, et al. Primary cutaneous cryptococcosis and a surprise finding in a chronically
immunosuppressed patient. JMM Case Reports. 2014;1(3).
15. Ying-Yi Lu, Chieh-Shan Wu C-HH. Primary cutaneous cryptococcosis in an
immunocompetent man: A case report. Dermatologica Sin. 2013;31:90–3.
16. Robiatul Adawiyah RW. Kriptokokosis : Epidemiologi, Manifestasi Klinis dan Diagnosis.
Maj Kedokt FK UKI. 2012;28(3):133–43.
17. Jennifer Wang, Luther Bartelt, Deborah Yu, Anjali Joshi, Bradley Weinbaum, Tiffany
Pierson, Michael Patrizio, Cirle A. Warren, Molly A. Hughes GD. Primary Cutaneous
Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an
 Immunosuppressed Patient: A Case Report and Review of the Literature. Case Rep Infect
Dis. 2015;1–8.
18. I. Samad, M. C. Wang VHC. Intracerebral coinfection with Burkholderia pseudomallei
and Cryptococcus neo- formans in a patient with systemic lupus erythematosus. Southeast
Asian J Trop Med Public Heal. 2014;45(2):352–356.